Oxis Intl Inc (OXIS) 0.0235 $OXIS
Top 5 Cannabis Stocks to Watch in 2015
ACCESSWIRE - Wed Feb 11, 8:39AM CST
CORAL GABLES, FL / ACCESSWIRE / February 11, 2015 / It's been a long and rough road for a push toward universal legalization of marijuana in the US. Since the early beginnings in California many decades ago with medical marijuana to the latest trail being blazed from states like Colorado, Oregon, Washington, and Alaska, this has certainly become a growth driven marketplace full of opportunity. It seems like those entering the space are facing the "kid in a candy store" mentality as so many industry assets can be applied to this new sector. From consulting services to biotech, there is a myriad of options for companies to focus on during these early stages. But the question remains, "Are 'pot' stocks really delivering for investors?" So, which stocks should you be in right now?
Oxis Biotech Inc. Provides Update for P62-ZZ Multiple Myeloma Patent Application
PR Newswire - Wed Feb 04, 6:30AM CST
Oxis International, Inc. (OXIS) (OXI.PA) a biotechnology company focused on cannabinoid therapy development and commercialization, provided today an update on its P62-ZZ Chemical Inhibitor and Therapeutic Potential for Multiple Myeloma patent application for shareholders and other interested parties.
Fresh Press Coming From Several Cannabis Related Companies
ACCESSWIRE - Mon Feb 02, 7:30AM CST
MIAMI, FL / ACCESSWIRE / February 2, 2015 / There are many things that can have an impact on share volume. These include speculation, rumors, and actual material events. Over the last week, several cannabis related public companies have made announcements which may or may not have sparked increases in trading activities for Oxis International (OTCQB:OXIS), Electronic Cigarettes International Group, Ltd. (OTCQB:ECIG), and American Green, Inc. (OTC:ERBB).
Are You Cashing In On Cannabis With These Market Movers?
ACCESSWIRE - Thu Jan 29, 9:26AM CST
MIAMI, FL / ACCESSWIRE / January 29, 2015 / The cannabis space is slowly starting to shake off its "dark cloud". The industry is now open to bigger investment, more states have legalized the drug both for medical and recreational use, and even more are putting the wheels in motion for the 2016 ballot. Here are some of the more popular movers in the sector which have been gaining attention in 2015.
This Is Where The Investment Opportunity Is Right Now In Cannabis
Small Cap Reporter - at Seeking Alpha - Tue Jan 20, 11:25AM CST
INSY: 51.50 (-0.66), GWPH: 78.09 (+1.70)
Are These Cannabis Stocks In Your Winning Portfolio Right Now?
ACCESSWIRE - Tue Jan 20, 7:31AM CST
CORAL GABLES, FL / ACCESSWIRE / January 20, 2015 / Medical marijuana has been legalized in 23 states and the District of Columbia. Recreational marijuana is now legal in two states: Colorado and Washington. The market for legalized marijuana will grow by 64% between 2014 and 2015, cites State of Marijuana Markets, "Cannabis is one of the fastest-growing industries," Steve Berg tells The Huffington Post, "domestically, we weren't able to find any market that is growing as quickly."
Cannabusiness Takes Center Stage As Stocks Rally
ACCESSWIRE - Fri Jan 16, 7:51AM CST
CORAL GABLES, FL / ACCESSWIRE / January 16, 2015 / Recreational cannabis, federal government easement on policy, and increase support from the masses has propelled massive industry growth for cannabis companies this year. Investors have found that there have been many opportunities to turn a profit during these very early stages of this industry boom. As the market continues to grow and the hopes of a less risk filled sector arise, investors continue to look for opportunity as more companies join the marijuana revolution. According to MMJ Business Daily, 2015 is expected not only to see more investment dollars flow into the market but it could even outpace the growth rate seen in 2014. The reason? States like Nevada, Illinois, Massachusetts, Oregon, and Alaska have all been identified as industry drivers this year. Furthermore, the rise in "BIG MONEY" from some major investment funds has just started to hit the marijuana sector.
Cannabis Companies Are Back In The Spotlight For 2015 On Surging Volume & Big Announcements
ACCESSWIRE - Thu Jan 15, 7:53AM CST
CORAL GABLES, FL / ACCESSWIRE / January 15, 2015 / The cannabis industry has truly evolved through its first year of legalization. We've seen the good, bad, and ugly put so much pressure on the industry that investors have become incredibly savvy in terms of diligence prior to "jumping in the pool". Once a taboo marketplace is now attracting some major investments. Not only did Paypal co-founder Peter Thiel's Founders Fund invest in the industry but now we're seeing some of the big name, pro-cannabis celebrities continue to break down barriers and put their money into the market. Tommy Chong, the Marley family, and even successful Wall Street investors like George Soros are all putting up the "dough" for full legalization of cannabis in the US. With that, many cannabis companies have found a new momentum stride as the industry may be seeing its second boom.
Oxis Biotech Inc. Announces Appointment of Dr. James J Mulé to Scientific Advisory Board
PR Newswire - Thu Jan 15, 6:30AM CST
Oxis International, Inc. (OXIS) (OXI.PA) a biotechnology company focused on cannabinoid therapy development and commercialization, announced today, Dr. James J Mulé has joined the Scientific Advisory Board for its' wholly owned subsidiary, Oxis Biotech, Inc.
Oxis Biotech Executes Worldwide Exclusive Patent Licensing "P62 Chemical Agents and Multiple Myeloma Therapeutics" with Dr. Xiang-Qun (Sean) Xie, Professor of Pharmaceutical Sciences at University of Pittsburgh
PR Newswire - Mon Jan 12, 6:30AM CST
Oxis International, Inc. (OXIS) (OXI.PA) a biotechnology company focused on cannabinoid therapy development and commercialization, announced today, wholly owned subsidiary Oxis Biotech, Inc. executed definitive agreements licensing certain assets for the treatment of Multiple Myeloma and initiated a consulting agreement with University of Pittsburgh's Professor, Dr. Xiang-Qun(Sean)Xie. The license agreement provides Oxis Biotech, Inc an exclusive worldwide license to develop and commercialize therapies for the treatment of Multiple Myeloma. Dr. Xie joins Oxis Biotech as a consultant and member of the Science Advisory Board to further develop the assets licensed to Oxis Biotech, Inc.
OXIS International, Inc. announces Changes in Management Team
PR Newswire - Thu Nov 20, 5:00PM CST
Oxis International, Inc. (OXIS) (OXI.PA) announced today the resignation of Ken Eaton, the election of Anthony J. Cataldo as Chief Executive Officer, and Steven Weldon as President.
OXIS International announces plans to Enter the Cannabis Biotech Sector, Completion of Financing, Changes to the Board of Directors
PR Newswire - Sun Aug 10, 11:33PM CDT
Oxis International, Inc. (OXI.PA) announced today company management has changed the business and plans to enter the cannabis biotech space. To support the change of business, the company completed a $1.425 million financing. Mr. Anthony Cataldo has joined the OXIS Board of Directors and will serve as Chairman of the Board.
Top 5 Cannabis Stocks to Watch in 2015
ACCESSWIRE - Wed Feb 11, 8:39AM CST
CORAL GABLES, FL / ACCESSWIRE / February 11, 2015 / It's been a long and rough road for a push toward universal legalization of marijuana in the US. Since the early beginnings in California many decades ago with medical marijuana to the latest trail being blazed from states like Colorado, Oregon, Washington, and Alaska, this has certainly become a growth driven marketplace full of opportunity. It seems like those entering the space are facing the "kid in a candy store" mentality as so many industry assets can be applied to this new sector. From consulting services to biotech, there is a myriad of options for companies to focus on during these early stages. But the question remains, "Are 'pot' stocks really delivering for investors?" So, which stocks should you be in right now?
Oxis Biotech Inc. Provides Update for P62-ZZ Multiple Myeloma Patent Application
PR Newswire - Wed Feb 04, 6:30AM CST
Oxis International, Inc. (OXIS) (OXI.PA) a biotechnology company focused on cannabinoid therapy development and commercialization, provided today an update on its P62-ZZ Chemical Inhibitor and Therapeutic Potential for Multiple Myeloma patent application for shareholders and other interested parties.
Fresh Press Coming From Several Cannabis Related Companies
ACCESSWIRE - Mon Feb 02, 7:30AM CST
MIAMI, FL / ACCESSWIRE / February 2, 2015 / There are many things that can have an impact on share volume. These include speculation, rumors, and actual material events. Over the last week, several cannabis related public companies have made announcements which may or may not have sparked increases in trading activities for Oxis International (OTCQB:OXIS), Electronic Cigarettes International Group, Ltd. (OTCQB:ECIG), and American Green, Inc. (OTC:ERBB).
Are You Cashing In On Cannabis With These Market Movers?
ACCESSWIRE - Thu Jan 29, 9:26AM CST
MIAMI, FL / ACCESSWIRE / January 29, 2015 / The cannabis space is slowly starting to shake off its "dark cloud". The industry is now open to bigger investment, more states have legalized the drug both for medical and recreational use, and even more are putting the wheels in motion for the 2016 ballot. Here are some of the more popular movers in the sector which have been gaining attention in 2015.
This Is Where The Investment Opportunity Is Right Now In Cannabis
Small Cap Reporter - at Seeking Alpha - Tue Jan 20, 11:25AM CST
INSY: 51.50 (-0.66), GWPH: 78.09 (+1.70)
Are These Cannabis Stocks In Your Winning Portfolio Right Now?
ACCESSWIRE - Tue Jan 20, 7:31AM CST
CORAL GABLES, FL / ACCESSWIRE / January 20, 2015 / Medical marijuana has been legalized in 23 states and the District of Columbia. Recreational marijuana is now legal in two states: Colorado and Washington. The market for legalized marijuana will grow by 64% between 2014 and 2015, cites State of Marijuana Markets, "Cannabis is one of the fastest-growing industries," Steve Berg tells The Huffington Post, "domestically, we weren't able to find any market that is growing as quickly."
Cannabusiness Takes Center Stage As Stocks Rally
ACCESSWIRE - Fri Jan 16, 7:51AM CST
CORAL GABLES, FL / ACCESSWIRE / January 16, 2015 / Recreational cannabis, federal government easement on policy, and increase support from the masses has propelled massive industry growth for cannabis companies this year. Investors have found that there have been many opportunities to turn a profit during these very early stages of this industry boom. As the market continues to grow and the hopes of a less risk filled sector arise, investors continue to look for opportunity as more companies join the marijuana revolution. According to MMJ Business Daily, 2015 is expected not only to see more investment dollars flow into the market but it could even outpace the growth rate seen in 2014. The reason? States like Nevada, Illinois, Massachusetts, Oregon, and Alaska have all been identified as industry drivers this year. Furthermore, the rise in "BIG MONEY" from some major investment funds has just started to hit the marijuana sector.
Cannabis Companies Are Back In The Spotlight For 2015 On Surging Volume & Big Announcements
ACCESSWIRE - Thu Jan 15, 7:53AM CST
CORAL GABLES, FL / ACCESSWIRE / January 15, 2015 / The cannabis industry has truly evolved through its first year of legalization. We've seen the good, bad, and ugly put so much pressure on the industry that investors have become incredibly savvy in terms of diligence prior to "jumping in the pool". Once a taboo marketplace is now attracting some major investments. Not only did Paypal co-founder Peter Thiel's Founders Fund invest in the industry but now we're seeing some of the big name, pro-cannabis celebrities continue to break down barriers and put their money into the market. Tommy Chong, the Marley family, and even successful Wall Street investors like George Soros are all putting up the "dough" for full legalization of cannabis in the US. With that, many cannabis companies have found a new momentum stride as the industry may be seeing its second boom.
Oxis Biotech Inc. Announces Appointment of Dr. James J Mulé to Scientific Advisory Board
PR Newswire - Thu Jan 15, 6:30AM CST
Oxis International, Inc. (OXIS) (OXI.PA) a biotechnology company focused on cannabinoid therapy development and commercialization, announced today, Dr. James J Mulé has joined the Scientific Advisory Board for its' wholly owned subsidiary, Oxis Biotech, Inc.
Oxis Biotech Executes Worldwide Exclusive Patent Licensing "P62 Chemical Agents and Multiple Myeloma Therapeutics" with Dr. Xiang-Qun (Sean) Xie, Professor of Pharmaceutical Sciences at University of Pittsburgh
PR Newswire - Mon Jan 12, 6:30AM CST
Oxis International, Inc. (OXIS) (OXI.PA) a biotechnology company focused on cannabinoid therapy development and commercialization, announced today, wholly owned subsidiary Oxis Biotech, Inc. executed definitive agreements licensing certain assets for the treatment of Multiple Myeloma and initiated a consulting agreement with University of Pittsburgh's Professor, Dr. Xiang-Qun(Sean)Xie. The license agreement provides Oxis Biotech, Inc an exclusive worldwide license to develop and commercialize therapies for the treatment of Multiple Myeloma. Dr. Xie joins Oxis Biotech as a consultant and member of the Science Advisory Board to further develop the assets licensed to Oxis Biotech, Inc.
OXIS International, Inc. announces Changes in Management Team
PR Newswire - Thu Nov 20, 5:00PM CST
Oxis International, Inc. (OXIS) (OXI.PA) announced today the resignation of Ken Eaton, the election of Anthony J. Cataldo as Chief Executive Officer, and Steven Weldon as President.
OXIS International announces plans to Enter the Cannabis Biotech Sector, Completion of Financing, Changes to the Board of Directors
PR Newswire - Sun Aug 10, 11:33PM CDT
Oxis International, Inc. (OXI.PA) announced today company management has changed the business and plans to enter the cannabis biotech space. To support the change of business, the company completed a $1.425 million financing. Mr. Anthony Cataldo has joined the OXIS Board of Directors and will serve as Chairman of the Board.
